Login
Coverage Universe
Drugs Covered:
3,865
Catalysts Covered:
5,346
Revenue Models:
410
Companies Covered:
932
Companies Evaluated:
27
>>
Advanced Catalyst Search
<<
>>
Advanced Drug Search
<<
>>
Advanced Event Search
<<
Search
Catalysts
Drug Profiles
Impact Events
Company Profiles
Target
Indication
Sample Reports
Special Reports
02/04/10
2010 BioMedTracker Outlook Report
01/19/10
JP Morgan Conference Review
12/21/09
2009 Post-ASH Report
11/30/09
2009 Pre-ASH Report
11/19/09
Vivus (VVUS) Coverage Initiation
11/13/09
H1N1 Influenza Pandemic Tracker
11/02/09
2009 Post-ACR Report
10/15/09
ACR Conference Catalysts
More...
Event Alerts
Date
Lead
Company
Event
Type
Approval
Change
Approval
Likelihood
02/08/10
Cell Therapeutics (CTIC)
Pixuvri for Non-Hodgkin's Lymphoma (NHL)
Subscribers Only
Subscribers Only
Subscribers Only
02/08/10
Forest (FRX)
Namenda - IR and ER for Alzheimer's Disease (AD)
Subscribers Only
Subscribers Only
Subscribers Only
02/08/10
Genta (GETA)
Tesetaxel for Melanoma
Subscribers Only
Subscribers Only
Subscribers Only
02/08/10
Amgen (AMGN)
Prolia - Oncology for Bone Complications (including bone metastases)
Subscribers Only
Subscribers Only
Subscribers Only
02/05/10
AMAG (AMAG)
Feraheme for Anemia Due to Chronic Renal Failure, Dialysis-Independent
Subscribers Only
Subscribers Only
Subscribers Only
Expected
Date Range
Lead
Company
Drug
Expected
Catalyst
02/09/10
Subscribers Only
Subscribers Only
Trial Announcement - Patient Enrollment Completed
02/09/10
Subscribers Only
Subscribers Only
Regulatory - Individual Country Filing (Europe)
02/09/10
Subscribers Only
Subscribers Only
Company - Earnings Announcement
02/09/10
Subscribers Only
Subscribers Only
Company - Earnings Announcement
02/09/10
Subscribers Only
Subscribers Only
Regulatory - PDUFA/Approval Decision (US)
Questions?
Email
Customer Support
Privacy Policy
Important Legal Disclosure
Copyright © 2010 Sagient Research Systems, Inc. All rights reserved.